BiotechTube
Home/Neurolief/Scott Drees
SD

Scott Drees

Chief Executive Officer

Neurolief

Therapeutic Areas

NeurologyPsychiatry

Neurolief Pipeline

DrugIndicationPhase
Relivion MGAcute and chronic migraineCommercial
Proliv™RxMajor depressive disorderPhase 2

Leadership Team at Neurolief

AD
Amit Dar
Chief Technology Officer
TB
Tony Borowicz
Chief Financial Officer
SB
Steve Beller
Chief Commercial Officer
RB
Ron Belson
Vice President, Research & Development
DL
Dganit Litinsky
Vice President, Regulatory & Quality
AC
Amir Cohen
Clinical Development Director
View full Neurolief profile